MUFG Securities Americas’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Buy
48,894
+1,280
+3% +$284K 0.69% 21
2025
Q4
$10.9M Sell
47,614
-24
-0.1% -$5.47K 0.68% 20
2025
Q3
$11M Buy
47,638
+8,490
+22% +$1.73M 0.71% 22
2025
Q2
$7.27M Buy
39,148
+7,899
+25% +$1.47M 0.62% 24
2025
Q1
$6.55M Buy
31,249
+5,163
+20% +$1M 0.76% 24
2024
Q4
$4.64M Buy
+26,086
New +$4.8M 0.59% 30

Other funds holding ABBV

MUFG Securities Americas's ABBV Position: Q1 2026 in Review

MUFG Securities Americas increased its AbbVie (ABBV) stake by 2.7% in Q1 2026, buying an estimated $284K and bringing the position to 48,894 shares worth $10.6M. The position accounts for 0.69% of the portfolio, ranked #21.

MUFG Securities Americas first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $11M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MUFG Securities Americas held 48,894 shares of AbbVie worth $10.6M as of Q1 2026.
  • MUFG Securities Americas bought 1,280 AbbVie shares in Q1 2026, an estimated $284K.
  • AbbVie made up 0.69% of MUFG Securities Americas's portfolio in Q1 2026, its #21 holding.
  • MUFG Securities Americas first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's AbbVie position peaked at $11M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.